Lifestance Health Group Stock Performance
| LFST Stock | USD 7.04 0.09 1.26% |
On a scale of 0 to 100, Lifestance Health holds a performance score of 10. The company secures a Beta (Market Risk) of 0.46, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Lifestance Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lifestance Health is expected to be smaller as well. Please check Lifestance Health's sortino ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Lifestance Health's current price movements will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Lifestance Health Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Lifestance Health unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.26) | Five Day Return (0.85) | Year To Date Return (6.75) | Ten Year Return (67.85) | All Time Return (67.85) |
1 | Disposition of 61508 shares by Ryan Pardo of Lifestance Health at 5.4 subject to Rule 16b-3 | 10/17/2025 |
2 | LifeStance Health Group, Inc. Stock Analysis Exploring a 61.5 percent Upside Potential in the Mental Health Sector - DirectorsTalk Interviews | 10/21/2025 |
3 | Does Calm Health Partnership Signal a New Growth Path for LifeStance Health Group | 11/06/2025 |
4 | Disposition of 10623 shares by Lisa Miller of Lifestance Health at 6.43 subject to Rule 16b-3 | 11/10/2025 |
5 | Is LifeStance Health Group Inc. stock a good choice for value investors - Options Play Long-Term Capital Growth Ideas - newser.com | 11/14/2025 |
6 | Wall Street Analysts Think LifeStance Health Could Surge 30.49 percent Read This Before Placing a Bet | 11/28/2025 |
7 | Should I hold or sell LifeStance Health Group Inc. stock in 2025 - July 2025 Snapshot Consistent Income Trade Recommendations - Newser | 12/02/2025 |
8 | LifeStance Health Group Now Covered by Analysts at Barclays - MarketBeat | 12/09/2025 |
9 | BTIG Research Boosts LifeStance Health Group Price Target to 10.00 | 12/12/2025 |
10 | Disposition of 6186 shares by Bessler Robert of Lifestance Health at 7.0 subject to Rule 16b-3 | 12/15/2025 |
11 | LifeStance Health Group, Inc. Receives 9.00 Average PT from Brokerages | 12/16/2025 |
12 | Disposition of 50000 shares by Ann Varanakis of Lifestance Health at 6.9 subject to Rule 16b-3 | 12/17/2025 |
13 | Disposition of 3221 shares by Bessler Robert of Lifestance Health at 7.0 subject to Rule 16b-3 | 12/18/2025 |
14 | Disposition of 850 shares by Bessler Robert of Lifestance Health at 7.04 subject to Rule 16b-3 | 12/22/2025 |
15 | Disposition of 2450 shares by Bessler Robert of Lifestance Health at 7.01 subject to Rule 16b-3 | 12/26/2025 |
| Begin Period Cash Flow | 78.8 M | |
| Total Cashflows From Investing Activities | -21.6 M |
Lifestance | Build AI portfolio with Lifestance Stock |
Lifestance Health Relative Risk vs. Return Landscape
If you would invest 535.00 in Lifestance Health Group on October 2, 2025 and sell it today you would earn a total of 178.00 from holding Lifestance Health Group or generate 33.27% return on investment over 90 days. Lifestance Health Group is currently generating 0.5318% in daily expected returns and assumes 4.1803% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Lifestance, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lifestance Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifestance Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lifestance Health Group, and traders can use it to determine the average amount a Lifestance Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1272
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LFST | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Lifestance Health is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lifestance Health by adding it to a well-diversified portfolio.
Lifestance Health Fundamentals Growth
Lifestance Stock prices reflect investors' perceptions of the future prospects and financial health of Lifestance Health, and Lifestance Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lifestance Stock performance.
| Return On Equity | -0.0062 | ||||
| Return On Asset | 0.0026 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 3.03 B | ||||
| Shares Outstanding | 389 M | ||||
| Price To Book | 1.86 X | ||||
| Price To Sales | 2.03 X | ||||
| Revenue | 1.25 B | ||||
| Gross Profit | 444.24 M | ||||
| EBITDA | 39.87 M | ||||
| Net Income | (57.44 M) | ||||
| Cash And Equivalents | 96.69 M | ||||
| Cash Per Share | 0.26 X | ||||
| Total Debt | 485.19 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 2.19 X | ||||
| Book Value Per Share | 3.84 X | ||||
| Cash Flow From Operations | 107.26 M | ||||
| Earnings Per Share | (0.03) X | ||||
| Market Capitalization | 2.77 B | ||||
| Total Asset | 2.12 B | ||||
| Retained Earnings | (818.29 M) | ||||
| Working Capital | 83.62 M | ||||
About Lifestance Health Performance
Assessing Lifestance Health's fundamental ratios provides investors with valuable insights into Lifestance Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Lifestance Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 26.84 | 23.86 | |
| Return On Tangible Assets | (0.09) | (0.10) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.04) | (0.04) |
Things to note about Lifestance Health performance evaluation
Checking the ongoing alerts about Lifestance Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lifestance Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lifestance Health appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 1.25 B. Net Loss for the year was (57.44 M) with profit before overhead, payroll, taxes, and interest of 444.24 M. | |
| Lifestance Health has a poor financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 2450 shares by Bessler Robert of Lifestance Health at 7.01 subject to Rule 16b-3 |
- Analyzing Lifestance Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lifestance Health's stock is overvalued or undervalued compared to its peers.
- Examining Lifestance Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lifestance Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lifestance Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lifestance Health's stock. These opinions can provide insight into Lifestance Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Lifestance Stock Analysis
When running Lifestance Health's price analysis, check to measure Lifestance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifestance Health is operating at the current time. Most of Lifestance Health's value examination focuses on studying past and present price action to predict the probability of Lifestance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifestance Health's price. Additionally, you may evaluate how the addition of Lifestance Health to your portfolios can decrease your overall portfolio volatility.